Nanobiotix S.A. ADR (NBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | -7,781 | 39,187 | 5,032 | 3,132 | 2,870 |
| Gross Profit | -7,781 | 39,187 | 5,032 | 3,132 | 2,870 |
| Operating Expenses | 66,227 | 68,171 | 54,237 | 65,338 | 44,482 |
| Operating Income | -74,007 | -28,983 | -49,205 | -62,206 | -41,612 |
| Interest Expense | 8,103 | 16,021 | 14,606 | 923 | -3,023 |
| Other Income | 8,493 | 2,167 | 3,723 | 7,526 | 230 |
| Pre-tax Income | -73,616 | -42,837 | -60,088 | -55,603 | -38,360 |
| Income Tax | 109 | 130 | 11 | 6 | 10 |
| Net Income Continuous | -73,726 | -42,967 | -60,098 | -55,609 | -38,370 |
| Net Income | $-73,726 | $-42,967 | $-60,098 | $-55,609 | $-38,370 |
| EPS Basic Total Ops | -1.56 | -1.17 | -1.73 | -1.60 | -1.58 |
| EPS Basic Continuous Ops | -1.56 | -1.16 | -1.72 | -1.60 | -1.57 |
| EPS Diluted Total Ops | -1.56 | -1.17 | -1.73 | -1.60 | -1.58 |
| EPS Diluted Continuous Ops | -1.56 | -1.16 | -1.72 | -1.60 | -1.57 |
| EPS Diluted Before Non-Recurring Items | -1.56 | -1.17 | -1.76 | -1.60 | -1.60 |
| EBITDA(a) | $-72,254 | $-27,347 | $-47,625 | $-60,361 | $-39,609 |